A citation-based method for searching scientific literature

Chunxiao Li, Xiaofei Xu, Shuhua Wei, Ping Jiang, Lixiang Xue, Junjie Wang. J Immunother Cancer 2021
Times Cited: 4







List of co-cited articles
50 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors.
Shahneen K Sandhu, Kyri Papadopoulos, Peter C Fong, Amita Patnaik, Christina Messiou, David Olmos, George Wang, Brenda J Tromp, Thomas A Puchalski, Frances Balkwill,[...]. Cancer Chemother Pharmacol 2013
147
75

Tumour-associated macrophages as treatment targets in oncology.
Alberto Mantovani, Federica Marchesi, Alberto Malesci, Luigi Laghi, Paola Allavena. Nat Rev Clin Oncol 2017
75

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.
Alberto Mantovani, Silvano Sozzani, Massimo Locati, Paola Allavena, Antonio Sica. Trends Immunol 2002
75

Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Xiaoguang Li, Wenbo Yao, Ya Yuan, Peizhan Chen, Bin Li, Jingquan Li, Ruiai Chu, Haiyun Song, Dong Xie, Xiaoqing Jiang,[...]. Gut 2017
258
75

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.
Timothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, Brian A Belt, Roheena Z Panni, Brian M Cusworth, Adetunji T Toriola, Rebecca K Nieman, Lori A Worley, Motoyo Yano,[...]. Lancet Oncol 2016
336
75

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer.
Kenneth J Pienta, Jean-Pascal Machiels, Dirk Schrijvers, Boris Alekseev, Mikhail Shkolnik, Simon J Crabb, Susan Li, Shobha Seetharam, Thomas A Puchalski, Chris Takimoto,[...]. Invest New Drugs 2013
188
75

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.
Haihui Lu, Karl R Clauser, Wai Leong Tam, Julia Fröse, Xin Ye, Elinor Ng Eaton, Ferenc Reinhardt, Vera S Donnenberg, Rohit Bhargava, Steven A Carr,[...]. Nat Cell Biol 2014
260
50


Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials.
Heleen H Van Acker, Sébastien Anguille, Yannick Willemen, Evelien L Smits, Viggo F Van Tendeloo. Pharmacol Ther 2016
94
50

Macrophage plasticity, polarization, and function in health and disease.
Abbas Shapouri-Moghaddam, Saeed Mohammadian, Hossein Vazini, Mahdi Taghadosi, Seyed-Alireza Esmaeili, Fatemeh Mardani, Bita Seifi, Asadollah Mohammadi, Jalil T Afshari, Amirhossein Sahebkar. J Cell Physiol 2018
965
50

Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy.
Russell Hughes, Bin-Zhi Qian, Charlotte Rowan, Munitta Muthana, Ioanna Keklikoglou, Oakley C Olson, Simon Tazzyman, Sarah Danson, Christina Addison, Mark Clemons,[...]. Cancer Res 2015
218
50

Targeting tumor-associated macrophages as an antitumor strategy.
Nan Cheng, Xuexia Bai, Yuxin Shu, Owais Ahmad, Pingping Shen. Biochem Pharmacol 2021
14
50

The cellular and molecular origin of tumor-associated macrophages.
Ruth A Franklin, Will Liao, Abira Sarkar, Myoungjoo V Kim, Michael R Bivona, Kang Liu, Eric G Pamer, Ming O Li. Science 2014
681
50

Microenvironmental regulation of tumour angiogenesis.
Michele De Palma, Daniela Biziato, Tatiana V Petrova. Nat Rev Cancer 2017
680
50

Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis.
Vladimir Riabov, Alexandru Gudima, Nan Wang, Amanda Mickley, Alexander Orekhov, Julia Kzhyshkowska. Front Physiol 2014
299
50

Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.
Laura Carminati, Denise Pinessi, Patrizia Borsotti, Lucia Minoli, Raffaella Giavazzi, Maurizio D'Incalci, Dorina Belotti, Giulia Taraboletti. Carcinogenesis 2019
17
50

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.
Jennifer L Guerriero, Alaba Sotayo, Holly E Ponichtera, Jessica A Castrillon, Alexandra L Pourzia, Sara Schad, Shawn F Johnson, Ruben D Carrasco, Suzan Lazo, Roderick T Bronson,[...]. Nature 2017
243
50

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.
Amira A Barkal, Kipp Weiskopf, Kevin S Kao, Sydney R Gordon, Benyamin Rosental, Ying Y Yiu, Benson M George, Maxim Markovic, Nan G Ring, Jonathan M Tsai,[...]. Nat Immunol 2018
150
50

CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.
Alan L Chang, Jason Miska, Derek A Wainwright, Mahua Dey, Claudia V Rivetta, Dou Yu, Deepak Kanojia, Katarzyna C Pituch, Jian Qiao, Peter Pytel,[...]. Cancer Res 2016
262
50

Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages.
Alessio Menga, Marina Serra, Simona Todisco, Carla Riera-Domingo, Ummi Ammarah, Manuel Ehling, Erika M Palmieri, Maria Antonietta Di Noia, Rosanna Gissi, Maria Favia,[...]. EMBO Mol Med 2020
8
50

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.
Gregory L Beatty, Elena G Chiorean, Matthew P Fishman, Babak Saboury, Ursina R Teitelbaum, Weijing Sun, Richard D Huhn, Wenru Song, Dongguang Li, Leslie L Sharp,[...]. Science 2011
50

Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
Dongbo Li, Hongfei Ji, Xingjian Niu, Lei Yin, Yiran Wang, Yucui Gu, Jinlu Wang, Xiaoping Zhou, Han Zhang, Qingyuan Zhang. Cancer Sci 2020
53
50

PI3Kγ is a molecular switch that controls immune suppression.
Megan M Kaneda, Karen S Messer, Natacha Ralainirina, Hongying Li, Christopher J Leem, Sara Gorjestani, Gyunghwi Woo, Abraham V Nguyen, Camila C Figueiredo, Philippe Foubert,[...]. Nature 2016
531
50

Tumor-associated myeloid cells: diversity and therapeutic targeting.
Alberto Mantovani, Federica Marchesi, Sebastien Jaillon, Cecilia Garlanda, Paola Allavena. Cell Mol Immunol 2021
13
50

Macrophages in Tissue Repair, Regeneration, and Fibrosis.
Thomas A Wynn, Kevin M Vannella. Immunity 2016
50

Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors.
Elisa Gomez Perdiguero, Kay Klapproth, Christian Schulz, Katrin Busch, Emanuele Azzoni, Lucile Crozet, Hannah Garner, Celine Trouillet, Marella F de Bruijn, Frederic Geissmann,[...]. Nature 2015
50

CD40 Agonist Antibodies in Cancer Immunotherapy.
Robert H Vonderheide. Annu Rev Med 2020
121
50

Phagocytosis checkpoints as new targets for cancer immunotherapy.
Mingye Feng, Wen Jiang, Betty Y S Kim, Cheng Cheng Zhang, Yang-Xin Fu, Irving L Weissman. Nat Rev Cancer 2019
165
50

Macrophages at the crossroads of anticancer strategies.
Nina Cortese, Matteo Donadon, Alessandra Rigamonti, Federica Marchesi. Front Biosci (Landmark Ed) 2019
13
50

The CD47-SIRPα Immune Checkpoint.
Meike E W Logtenberg, Ferenc A Scheeren, Ton N Schumacher. Immunity 2020
46
50

Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer.
Takanori Kitamura, Dahlia Doughty-Shenton, Luca Cassetta, Stamatina Fragkogianni, Demi Brownlie, Yu Kato, Neil Carragher, Jeffrey W Pollard. Front Immunol 2018
69
50


Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer.
Eun-Jin Yeo, Luca Cassetta, Bin-Zhi Qian, Ian Lewkowich, Jiu-feng Li, James A Stefater, April N Smith, Lisa S Wiechmann, Yihong Wang, Jeffrey W Pollard,[...]. Cancer Res 2014
103
50

SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy.
André Veillette, Jun Chen. Trends Immunol 2018
129
50

CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages.
Takanori Kitamura, Bin-Zhi Qian, Daniel Soong, Luca Cassetta, Roy Noy, Gaël Sugano, Yu Kato, Jiufeng Li, Jeffrey W Pollard. J Exp Med 2015
346
50

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.
Laura Bonapace, Marie-May Coissieux, Jeffrey Wyckoff, Kirsten D Mertz, Zsuzsanna Varga, Tobias Junt, Mohamed Bentires-Alj. Nature 2014
369
50

Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.
Dominic E Sanford, Brian A Belt, Roheena Z Panni, Allese Mayer, Anjali D Deshpande, Danielle Carpenter, Jonathan B Mitchem, Stacey M Plambeck-Suess, Lori A Worley, Brian D Goetz,[...]. Clin Cancer Res 2013
309
50

Pre-metastatic niches: organ-specific homes for metastases.
Héctor Peinado, Haiying Zhang, Irina R Matei, Bruno Costa-Silva, Ayuko Hoshino, Goncalo Rodrigues, Bethan Psaila, Rosandra N Kaplan, Jacqueline F Bromberg, Yibin Kang,[...]. Nat Rev Cancer 2017
664
50

Targeting the CCL2-CCR2 signaling axis in cancer metastasis.
Su Yin Lim, Arseniy E Yuzhalin, Alex N Gordon-Weeks, Ruth J Muschel. Oncotarget 2016
234
50

Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma.
Marcus Noel, Eileen M O'Reilly, Brian M Wolpin, David P Ryan, Andrea J Bullock, Carolyn D Britten, David C Linehan, Brian A Belt, Eric C Gamelin, Bishu Ganguly,[...]. Invest New Drugs 2020
39
50

CCL2/CCR2 Axis Promotes the Progression of Salivary Adenoid Cystic Carcinoma via Recruiting and Reprogramming the Tumor-Associated Macrophages.
Zihui Yang, Huan Li, Weiqi Wang, Jianying Zhang, Sen Jia, Jun Wang, Jianhua Wei, Delin Lei, Kaijin Hu, Xinjie Yang. Front Oncol 2019
22
50

Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Kun-Yu Teng, Jianfeng Han, Xiaoli Zhang, Shu-Hao Hsu, Shun He, Nissar A Wani, Juan M Barajas, Linda A Snyder, Wendy L Frankel, Michael A Caligiuri,[...]. Mol Cancer Ther 2017
56
50

Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study.
Irene Brana, Antonio Calles, Patricia M LoRusso, Lorrin K Yee, Thomas A Puchalski, Shobha Seetharam, Bob Zhong, Carla J de Boer, Josep Tabernero, Emiliano Calvo. Target Oncol 2015
85
50

A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth.
Binzhi Qian, Yan Deng, Jae Hong Im, Ruth J Muschel, Yiyu Zou, Jiufeng Li, Richard A Lang, Jeffrey W Pollard. PLoS One 2009
429
50

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
50

CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.
Joseph A Flores-Toro, Defang Luo, Adithya Gopinath, Matthew R Sarkisian, James J Campbell, Israel F Charo, Rajinder Singh, Thomas J Schall, Meenal Datta, Rakesh K Jain,[...]. Proc Natl Acad Sci U S A 2020
71
50

Macrophage activation and polarization: nomenclature and experimental guidelines.
Peter J Murray, Judith E Allen, Subhra K Biswas, Edward A Fisher, Derek W Gilroy, Sergij Goerdt, Siamon Gordon, John A Hamilton, Lionel B Ivashkiv, Toby Lawrence,[...]. Immunity 2014
50

M2 macrophages in kidney disease: biology, therapies, and perspectives.
Titi Chen, Qi Cao, Yiping Wang, David C H Harris. Kidney Int 2019
47
50

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis.
Anna-Maria Georgoudaki, Kajsa E Prokopec, Vanessa F Boura, Eva Hellqvist, Silke Sohn, Jeanette Östling, Rony Dahan, Robert A Harris, Mattias Rantalainen, Daniel Klevebring,[...]. Cell Rep 2016
259
50

CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy.
Alba Rodriguez-Garcia, Rachel C Lynn, Mathilde Poussin, Monika A Eiva, Lauren C Shaw, Roddy S O'Connor, Nicholas G Minutolo, Victoria Casado-Medrano, Gonzalo Lopez, Takami Matsuyama,[...]. Nat Commun 2021
18
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.